CA2233724C - Prevision et detection du rejet d'une homogreffe cardiaque - Google Patents

Prevision et detection du rejet d'une homogreffe cardiaque Download PDF

Info

Publication number
CA2233724C
CA2233724C CA 2233724 CA2233724A CA2233724C CA 2233724 C CA2233724 C CA 2233724C CA 2233724 CA2233724 CA 2233724 CA 2233724 A CA2233724 A CA 2233724A CA 2233724 C CA2233724 C CA 2233724C
Authority
CA
Canada
Prior art keywords
bnp
assay
levels
fragment
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2233724
Other languages
English (en)
Other versions
CA2233724A1 (fr
Inventor
Adolfo J. De Bold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ottawa Heart Institute Research Corp
Original Assignee
Ottawa Heart Institute Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ottawa Heart Institute Research Corp filed Critical Ottawa Heart Institute Research Corp
Priority to CA 2233724 priority Critical patent/CA2233724C/fr
Publication of CA2233724A1 publication Critical patent/CA2233724A1/fr
Application granted granted Critical
Publication of CA2233724C publication Critical patent/CA2233724C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA 2233724 1998-03-31 1998-03-31 Prevision et detection du rejet d'une homogreffe cardiaque Expired - Fee Related CA2233724C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2233724 CA2233724C (fr) 1998-03-31 1998-03-31 Prevision et detection du rejet d'une homogreffe cardiaque

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2233724 CA2233724C (fr) 1998-03-31 1998-03-31 Prevision et detection du rejet d'une homogreffe cardiaque

Publications (2)

Publication Number Publication Date
CA2233724A1 CA2233724A1 (fr) 1999-09-30
CA2233724C true CA2233724C (fr) 2004-05-11

Family

ID=29275460

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2233724 Expired - Fee Related CA2233724C (fr) 1998-03-31 1998-03-31 Prevision et detection du rejet d'une homogreffe cardiaque

Country Status (1)

Country Link
CA (1) CA2233724C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102323418A (zh) * 2011-08-31 2012-01-18 内蒙古科慧生物科技有限责任公司 B型利钠肽原前体(proBNP)定量测定试剂盒及其检测方法

Also Published As

Publication number Publication date
CA2233724A1 (fr) 1999-09-30

Similar Documents

Publication Publication Date Title
US6117644A (en) Predicting and detecting cardiac allograft rejection
Ng et al. Diagnosis of heart failure using urinary natriuretic peptides
CN101611314B (zh) 利用新颖标志物CT-proADM进行诊断和危险分层
US20050244902A1 (en) Methods for determining levels of human b-type natriuretic peptide precursors
US8501485B2 (en) Risk stratification for acute coronary syndrome by determining copeptin
EP2084544B1 (fr) Standards stables pour des immunodosages de bnp
Sagnella Measurement and importance of plasma brain natriuretic peptide and related peptides
US7977072B2 (en) Sandwich immunoassay for identifying partial proANP peptides
US20040265926A1 (en) Bodily fluid markers of tissue hypoxia
ZA200106193B (en) Method of identifying N-terminal proBNP.
US8263325B2 (en) Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis
EP1714158A2 (fr) Methodes pour diagnostiquer un syndrome coronarien aigu en mesurant le niveau de l'urotensine ii
US20190100576A1 (en) Signal biomarkers
JPH06174718A (ja) 心不全に対する検査方法
US20040077027A1 (en) Assays and kits for detecting and monitoring heart disease
CA2233724C (fr) Prevision et detection du rejet d'une homogreffe cardiaque
US5702910A (en) Method of sandwich immunoassay for N-peptide
EP2264463A2 (fr) Techniques de pronostic d'insuffisance cardiaque congestive
CN101600967B (zh) 和肽素或后叶激素运载蛋白ii在制备急性冠状动脉综合征危险性分级试剂盒的用途
JP4423426B2 (ja) アドレノメデュリン前駆体ｃ末端ペプチドの濃度の上昇を循環器疾患又は炎症性疾患の指標とする方法
CN100543471C (zh) 组织缺氧的体液指标
FI112117B (fi) Menetelmä ouabaiinin tai sen analogin mittaamiseksi plasmassa

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160331